Prediabetes and High Morning Blood Sugar: What the Number Means

A single high morning reading does not tell you whether you have diabetes, and a pattern of high morning readings with normal daytime readings is one of the most common ways impaired glucose regulation first shows up. Fasting plasma glucose between 100 and 125 mg/dL falls in the range clinicians label prediabetes, and 126 mg/dL or higher on two separate occasions is the threshold for diabetes. Those cutoffs apply to a venous plasma sample drawn after at least eight hours without food, not to a continuous glucose monitor (CGM) value or a fingerstick meter, both of which carry enough error to move you across a category boundary on their own. If your CGM shows 130 mg/dL at 7 a.m. and 95 mg/dL after lunch, the useful next step is to characterize the overnight trace properly and confirm it with a laboratory measurement, then take both to a clinician who can interpret them alongside your history.

What the morning number measures

Fasting glucose and post-meal glucose are reporting on different physiology. After an overnight fast, essentially all circulating glucose comes from the liver through glycogenolysis and gluconeogenesis. The rate of that output is set largely by how effectively insulin suppresses it. An elevated fasting value is therefore closer to a readout of hepatic insulin sensitivity than of pancreatic beta-cell reserve. Post-meal excursions depend more on first-phase insulin secretion, incretin response, and peripheral glucose uptake by muscle. People can have impaired fasting glucose with a normal oral glucose tolerance test, or the reverse. The two groups have different underlying defects, which is why a morning-only elevation is genuinely informative rather than a measurement error by default.

CGM work in people with normal glucose tolerance establishes what the reference case looks like: glucose stays within a narrow band for most of the 24-hour period, with brief post-meal peaks and a stable overnight plateau ¹. Against that background, an overnight plateau that sits at 105 to 120 mg/dL and drifts upward toward waking is a real signal even when every daytime value looks unremarkable. More recent work has shown that indices derived directly from CGM traces can detect reduced glucose handling capacity that fasting glucose and HbA1c miss, which argues for analyzing the shape of the curve rather than reading a single point off it ².

Why glucose rises before you wake

The dawn phenomenon is a circadian rise in cortisol and growth hormone secretion beginning roughly two to three hours before habitual waking. Both hormones increase hepatic glucose production and blunt peripheral insulin action, so glucose climbs from its overnight nadir into the early morning. In people with normal glucose tolerance the rise is modest, on the order of 10 to 20 mg/dL, and is offset by a compensating increase in insulin secretion. Where that compensation is incomplete, the same hormonal signal produces a much larger morning rise, and continuous monitoring in type 2 diabetes has been used specifically to quantify this pattern and separate it from postprandial effects ³.

A second, less common explanation is rebound after an overnight low, where counter-regulatory hormones overshoot. CGM is the only practical way to distinguish the two, because both end in a high waking value and only one has a nadir below 70 mg/dL at 3 a.m. Retrospective CGM has documented nocturnal hypoglycemia that fingerstick testing never captured, including in severe cases ⁴. If your trace shows genuine overnight lows, that is a finding to bring to a clinician promptly rather than something to tune yourself.

Getting a trustworthy number out of your CGM

Before interpreting anything, discard the data you should not trust. Dexcom G7 reports every five minutes, or 288 values per day. It exports from Clarity as a CSV with Timestamp (YYYY-MM-DDThh:mm:ss), Event Type, and Glucose Value (mg/dL). Values below 40 or above 400 appear as the strings Low and High, which will silently poison a float conversion if you do not handle them. Abbott’s LibreView export uses Device Timestamp and separates Historic Glucose mg/dL from Scan Glucose mg/dL, and mixing the two columns produces an irregular series. Sensor accuracy is characterized by mean absolute relative difference (MARD), around 8 to 10 percent for current systems, which means a displayed 118 mg/dL is consistent with a true value anywhere from roughly 105 to 130 ⁵.

The dominant overnight artifact is the compression low, caused by lying on the sensor and restricting interstitial flow. It looks like a rapid fall of 2 to 4 mg/dL per minute into the 40s or 50s, a flat floor for 20 to 90 minutes, and an equally abrupt recovery to the prior level with no food involved. Any analysis of overnight nadirs must screen these out. Also drop the first 12 to 24 hours after insertion, where readings often run low and noisy. Remember too that CGM measures interstitial fluid with a physiological lag of about 5 to 10 minutes behind plasma, which matters at the steep part of a dawn rise ⁶.

With that cleaned, the summary statistics worth computing per night are the 3 a.m. to 5 a.m. mean, the overnight minimum after artifact removal, your habitual wake-time value, and the slope between them:

import pandas as pd

df = pd.read_csv("clarity.csv", parse_dates=["Timestamp (YYYY-MM-DDThh:mm:ss)"])
df = df.rename(columns={"Timestamp (YYYY-MM-DDThh:mm:ss)": "ts",
                        "Glucose Value (mg/dL)": "mgdl"})
df["mgdl"] = pd.to_numeric(df["mgdl"].replace({"Low": 39, "High": 401}), errors="coerce")
df = df.dropna(subset=["mgdl"]).set_index("ts").sort_index()

# flag likely compression artifacts: fast drop, flat floor, fast recovery
rate = df["mgdl"].diff() / (df.index.to_series().diff().dt.total_seconds() / 60)
df["suspect"] = (rate < -2.0).rolling("60min").max().fillna(0).astype(bool)

night = df.between_time("03:00", "05:00")
plateau = night[~night["suspect"]].groupby(night.index.normalize())["mgdl"].mean()
wake = df.between_time("06:45", "07:15").groupby(lambda t: t.normalize())["mgdl"].mean()
print(pd.concat([plateau.rename("plateau_3_5am"), wake.rename("wake")], axis=1).describe())

Fourteen nights is a reasonable minimum before drawing conclusions, since night-to-night variance from sleep timing, alcohol, late meals, and illness is large. Professional and personal CGM are both used clinically for exactly this kind of pattern-finding over multi-week windows rather than single-day snapshots ⁷.

Confirming with lab chemistry and genomic context

CGM tells you the shape. A venous draw tells you where the axis is. Ask for the sample in a gray-top tube containing sodium fluoride and potassium oxalate, because glycolysis in a plain serum tube consumes glucose at roughly 5 to 7 percent per hour at room temperature, which can drag a 104 mg/dL result down to 95 before it reaches the analyzer. Pair it with HbA1c, where 5.7 to 6.4 percent is the prediabetes band. If available, add fasting insulin and C-peptide, which let you compute HOMA-IR and distinguish hepatic insulin resistance from reduced secretion.

HbA1c has genotype-dependent failure modes worth checking against whole-genome data. Hemoglobin variants such as HbS, HbC, and HbE interfere with some assay chemistries. Anything that shortens red cell lifespan, including G6PD deficiency and hereditary spherocytosis, biases HbA1c downward relative to true average glucose. Separately, heterozygous loss-of-function variants in GCK (glucokinase) produce a lifelong, stable and mildly elevated fasting glucose. It is typically 100 to 145 mg/dL with near-normal post-meal excursions and little progression over decades. That pattern is a high morning number with an otherwise flat CGM trace and a family history of the same. Sequencing changes the interpretation entirely here, so take it to a clinical geneticist or endocrinologist rather than resolve it from a variant call file alone.

What an isolated morning elevation does and does not establish

It establishes that hepatic glucose output is not being suppressed as tightly as it is in people with normal tolerance, and that the effect is large enough to survive the noise of a consumer sensor. An isolated elevation does not establish a diagnosis, because that requires laboratory confirmation on two occasions or an HbA1c, and it does not tell you the mechanism. Time in range, the fraction of readings between 70 and 180 mg/dL, is the metric that has been linked to long-term outcomes in diabetes and is a reasonable thing to track alongside the fasting value ⁸. Interventions studied in this population include meal-timing changes and app-based personalized feedback. A randomized crossover trial of time-restricted feeding in men at risk for type 2 diabetes improved glucose tolerance ⁹. Feedback apps have been tested in prediabetes and type 2 diabetes with modest effects ¹⁰. Whether either applies to you is a question for a clinician who has seen your full results.

Questions people also ask

Do I have diabetes if my blood sugar is only high in the morning? Not on that basis alone. Isolated impaired fasting glucose with normal post-meal values is a recognized pattern, and confirming it takes a laboratory fasting plasma glucose on two occasions or an HbA1c, interpreted by a clinician.

Is it normal to have blood sugar of 200 when I wake up? No. A fasting value near 200 mg/dL is well outside anything seen in normal glucose tolerance and meets thresholds clinicians use for diagnosis. Confirm it with a fingerstick or lab draw rather than the CGM alone, and contact a clinician.

What causes high morning glucose without diabetes? The dawn rise in cortisol and growth hormone, a late or alcohol-containing evening meal, poor or short sleep, acute illness, and certain medications all raise fasting glucose. Sensor compression artifacts and calibration drift can also create the appearance of a pattern that is not there.

What time of day is glucose highest? For most people it peaks 45 to 90 minutes after the largest meal of the day. The fasting trace has its own, smaller peak just before waking, and its nadir typically falls between 2 and 4 a.m.

How long after waking should I check? Take the fasting measurement before getting out of bed if you can. Do it before coffee, food or exercise, since all three move glucose within minutes. For CGM comparisons, fix a consistent 30-minute window and use the mean of the readings inside it rather than a single point.

Footnotes

1. Roger S. Mazze, Ellie Strock, David Wesley, et al. Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis. Diabetes Technology & Therapeutics, 2008. https://doi.org/10.1089/dia.2007.0293 ↩

2. Hikaru Sugimoto, Ken-ichi Hironaka, Tomoaki Nakamura, et al. Improved detection of decreased glucose handling capacities via continuous glucose monitoring-derived indices. Communications Medicine, 2025. https://doi.org/10.1038/s43856-025-00819-5 ↩

3. L. Monnier, C. Colette, C. Boegner, et al. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?. Diabetes & Metabolism, 2007. https://doi.org/10.1016/j.diabet.2006.11.007 ↩

4. Robert J. Tanenberg, Christopher A. Newton, Almond J. Drake. Confirmation of Hypoglycemia in the “Dead-In-Bed” Syndrome, as Captured by a Retrospective Continuous Glucose Monitoring System. Endocrine Practice, 2010. https://doi.org/10.4158/ep09260.cr ↩

5. Sandeep Vashist. Continuous Glucose Monitoring Systems: A Review. Diagnostics, 2013. https://doi.org/10.3390/diagnostics3040385 ↩

6. Bruce W. Bode. Clinical Utility of the Continuous Glucose Monitoring System. Diabetes Technology & Therapeutics, 2000. https://doi.org/10.1089/15209150050214104 ↩

7. Eugene E. Wright, James R. Gavin. Clinical Use of Professional Continuous Glucose Monitoring. Diabetes Technology & Therapeutics, 2017. https://doi.org/10.1089/dia.2017.0037 ↩

8. Jingyi Lu, Xiaojing Ma, Jian Zhou, et al. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care, 2018. https://doi.org/10.2337/dc18-1131 ↩

9. Amy T. Hutchison, Prashant Regmi, Emily N.C. Manoogian, et al. Time‐Restricted Feeding Improves Glucose Tolerance in Men at Risk for Type 2 Diabetes: A Randomized Crossover Trial. Obesity, 2019. https://doi.org/10.1002/oby.22449 ↩

10. Elena Lalama, Marta Csanalosi, Stefan Kabisch, et al. Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial. JMIR Human Factors, 2026. https://doi.org/10.2196/87692 ↩